A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Purpose An optimal target for glucose control in ICU patients remains unclear. This prospective randomized controlled trial compared the effects on ICU mortality of intensive insulin therapy (IIT) with an intermediate glucose control. Methods Adult patients admitted to the 21 participating medico-surgical ICUs were randomized to group 1 (target BG 7.8-10.0 mmol/L) or to group 2 (target BG 4.4-6.1 mmol/L). Results While the required sample size was 1,750 per group, the trial was stopped early due to a high rate of unintended protocol violations. From 1,101 admissions, the outcomes of 542 patients assigned to group 1 and 536 of group 2 were analysed. The groups were well balanced. BG levels averaged in group 1 8.0 mmol/L (IQR 7.1-9.0) (median of all values) and 7.7 mmol/L (IQR 6.7-8.8) (median of morning BG) versus 6.5 mmol/L (IQR 6.0-7.2) and 6.1 mmol/L (IQR 5.5-6.8) for group 2 (p Conclusions In this prematurely stopped and therefore underpowered study, there was a lack of clinical benefit of intensive insulin therapy (target 4.4-6.1 mmol/L), associated with an increased incidence of hypoglycaemia, as compared to a 7.8-10.0 mmol/L target. (ClinicalTrials.gov # NCT00107601, EUDRA-CT Number: 200400391440).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A retrospective study suggested that tidal volumes should be lowered even with plateau pressures ≤ 30 cm H 2 O (431) because lower plateau pressures were associated with reduced hospital mortality (432).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [431]
In the citing paper
“In the surgical ICU, earlier studies have indicated that intensive glucose control (80 to 110 mg/dL) inconsistently resulted in decreased length of stay.94–96”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [94]
In the citing paper
“Intensive glycemic control post-operatively, compared to less intensive targets, has resulted in equivocal or mixed results; however, other studies have shown no benefits.94,100,101,104”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [94]
In the citing paper
“Obese patients are only slightly more prevalent in the ICU than in the hospital and in the related populations.”
From ESPEN guideline on clinical nutrition in the intensive care unit. (2019) · cites this paper as [351]
In the citing paper
“There is a large variability in the prevalence between countries with more than 39% and 37% obese (BMI>30 kg/m 2 ) present in the US ICUs and hospital wards, 22% and 19% in Europe, 17% and 14% in South America and 10% and 7% in the Asian and Pacific region based on data from the Nutrition Day project (6,351).”
From ESPEN guideline on clinical nutrition in the intensive care unit. (2019) · cites this paper as [351]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“The Acute Physiological and Chronic Health Evaluation (APACHE II) on admission [11] and the daily Sequential Organ Failure Assessment (SOFA) [12] scores and the presence of diabetes were recorded.”
MethodVincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674 · cited 9×
“The overall severity of organ failures assessed by daily SOFA scores were similar in both groups as were the other severity indices of illness, the number of febrile days and the number of days with anti-infective agents, except for the number of patient days with vasopressors/inotropes which was higher in the group 2…”
MethodInfluentialIntensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 1×
“Nevertheless, the mortality was slightly and not significantly increased in the group 2, consistently with other recent prospective trials [7, 14, 18, 19].”
ResultIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 9×
“The proportion of time in range calculated from morning BG values was not lower than in the most of the other studies [6, 7, 13, 17].”
BackgroundMethodResultInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Riker, R. R. (2009) · JAMA · doi:10.1001/jama.2009.56 · Cited by 1,672
Dungan, K. M., Braithwaite, S. S., & Preiser, J.-C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60553-5 · Cited by 1,431
Self-citationKrinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165 · cited 1×
“with other recent findings [14, 25].”
Research works printed but not linked: 2
- Devos P, Preiser JC, Melot C (2007) Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucontrol study. Intensive Care Med 33:S189
- Devos P, Ledoux D, Preiser JC (2005) Current practice of glycaemia control in European intensive care units (ICUS). Intensive Care Med 31:S203
Cited by
Items 501–600 of 912
Frontera, J. A. (2010) · Neurocritical Care · doi:10.1007/s12028-010-9458-7 · Cited by 9
“Unacceptable rates of hypoglycemia led to the early termination of both the VISEP [27] and Glucontrol [28] studies.”
BackgroundResultArtificial pancreas: the past and the future
Kitagawa, H., Munekage, M., Seo, S., & Hanazaki, K. (2025) · Journal of Artificial Organs · doi:10.1007/s10047-025-01510-1 · Cited by 9
“Subsequent IIT studies, such as VISEP and GLUCONTROL, revealed a risk of severe hypoglycemia [45, 46].”
Is Glycemic Control of the Critically Ill Cost-Effective?
Krinsley, J. S. (2014) · Hospital Practice · doi:10.3810/hp.2014.10.1142 · Cited by 9
In Silico Evaluation of Glucose Control Protocols for Critically Ill Patients
Lee, J. C., Kim, M., Choi, K. R., Oh, T. J., Kim, M. Y., Cho, Y. M., Kim, K., Kim, H. C., & Kim, S. (2011) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2011.2163310 · Cited by 8
“Some tight glucose control clinical studies were stopped due to a high incidence of hypoglycemia [7].”
BackgroundKrinsley, J. S. (2014) · Hospital Practice · doi:10.3810/hp.2014.04.1099 · Cited by 9
Septic shock: The initial moments and beyond
Lam, S. W., Bauer, S. R., & Guzmán, J. A. (2013) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.80a.12002 · Cited by 8
“34,64 In the largest randomized controlled trial of this topic, with more than 6,000 patients, intensive insulin therapy with a target blood glucose level of 81 to 108 mg/dL was associated with a significantly higher mortality rate (odds ratio 1.14, 95% confidence interval 1.02–1.28, P = .02) than…”
BackgroundInfluentialFisk, L., Compte, A. J. L., Shaw, G. M., & Chase, J. G. (2012) · Journal of Healthcare Engineering · doi:10.1260/2040-2295.3.3.415 · Cited by 9
“Control Protocols Comparison Five different protocols were assessed in simulation on this virtual cohort: STAR [25], SPRINT [7] and three other published protocols: UNC [22], Yale [23] and Glucontrol A [24].”
BackgroundMethodInfluential[Management of parenteral nutrition in intensive care units in Spain].
Alonso, C. V., Mesejo, A., Escribano, J. A., & Santana, S. R. (2013) · PubMed · doi:10.3305/nh.2013.28.5.6815 · Cited by 8
Shah, B., Berger, J. S., Amoroso, N. S., Mai, X., Lorin, J. D., Danoff, A., Schwartzbard, A. Z., Lobach, I. V., Guo, Y., Feit, F., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.01.428 · Cited by 8
Punke, M. A., Goepfert, M. S., Kluge, S., Reichenspurner, H. C., Goetz, A. E., & Reuter, D. A. (2014) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2014.04.017 · Cited by 8
Glycemic Control and Nutrition
Preiser, J. (2011) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607111415981 · Cited by 8
Self-citationRodríguez-Calero, M. Á., Llodrá, E. B., Cuberos, M. C., Blanco‐Mavillard, I., & Axartell, M. A. P. (2018) · Enfermería Intensiva · doi:10.1016/j.enfi.2018.01.004 · Cited by 11
Brand, D. A., Peragallo‐Dittko, V., Fazzari, M. J., Islam, S., Jacobson, A. M., & Radin, M. S. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0498 · Cited by 8
The state of variability: A vision for descriptors of glycaemia
Zhou, T., Knopp, J. L., & Chase, J. G. (2019) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2019.06.004 · Cited by 8
Estimating Increased EGP During Stress Response in Critically Ill Patients
Ormsbee, J. J., Knopp, J. L., & Chase, J. G. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820922842 · Cited by 8
DuBose, J. J., Inaba, K., Branco, B. C., Barmparas, G., Lam, L., Teixeira, P. G., Belzberg, H., & Δημητριάδης, Δ. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.04.003 · Cited by 8
“[17] Preiser JC, Devos P, Ruiz-Santana S, et al.”
Avanzini, F., Marelli, G., Saltafossi, D., Longhi, C., Carbone, S., Carlino, L., Planca, E., Vilei, V., Roncaglioni, M. C., Riva, E., et al. (2015) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872615574110 · Cited by 8
Evaluation of 7.5 years of Surviving Sepsis Campaign Guidelines
Bakker, J., Perner, A., & Timsit, J. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3526-y · Cited by 8
“Fourth, glucose management, although initially found to improve outcome in an efficacy study [10], showed no effect or even an increase in mortality in efficiency studies [11, 12].”
BackgroundFriol, A., Devautour, C., Semenov, A., Pelle, J., Renaudier, M., Benghanem, S., Cariou, A., Mira, J. P., Charpentier, J., & Pène, F. (2025) · Annals of Intensive Care · doi:10.1186/s13613-025-01596-z · Cited by 7
“…These studies compared intensive insulin therapy, aiming for blood glucose levels between 80 and 110 mg/dL (4.4–6.1 mmol/L) [33, 35], with conventional insulin therapy initiated when blood glucose levels exceeded 140–180 mg/dL (7.8–10 mmol/L) [33, 36] or 180–215 mg/dL (10.0-11.9 mmol/L) [33, 35].”
InfluentialGlycemic variability and mortality in oncologic intensive care units
de Oliveira, A. P., Castro, M. D. S., & de Lima, D. V. M. (2023) · Revista Brasileira de Enfermagem · doi:10.1590/0034-7167-2022-0812 · Cited by 7
“The analyzed results showed no difference in the mortality rate in the ICU, the length of stay in the ICU, and the length of hospital stay between the two groups(16).”
ResultAssociation between Admission Hyperglycemia and Length of Stay after Renal Transplantation
Tewari, S., Kathuria, A., Meier‐Kriesche, H., & Lansang, M. C. (2010) · Endocrine Practice · doi:10.4158/ep09290.or · Cited by 7
Okawa, M., Kunimoto, F., Kanamoto, M., Narahara, H., Hinohara, H., Tobe, M., Yanagisawa, A., & Saito, S. (2012) · Journal of Diabetes · doi:10.1111/1753-0407.12010 · Cited by 7
“Previous RCTs described only the incidence of serious hypoglycemia (<40 mg/dL) and did not report on the incidence of moderate hypoglycemia (<60 mg/dL).(4,5,13) The mean (±SD) blood glucose level of 133 ± 38 mg/dL in the present study was higher than that reported in previous RCTs(4,5,13) using the Leuven protocol.”
BackgroundResultManagement of the Pediatric Organ Donor
Beckman, E. J. (2019) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-24.4.276 · Cited by 7
Gómez, C. E. P., Durán, J. C., Estrada, V. H. N., VALENCIA, B. A. G., Zaccaro, L. F., Castell, C. R. D., Meza, C. C., Polo, Y. M. Z., Vega, F. V., Fernández, M. G., et al. (2023) · Acta Colombiana de Cuidado Intensivo · doi:10.1016/j.acci.2023.04.007 · Cited by 7
Control glucémico en el enfermo crítico: comparación de dos protocolos de insulinización intravenosa
Raurell‐Torredà, M., Serrano, C. D. L., Almirall-Solsona, D., Catalán-Ibars, R. M., & Arfelis, J. M. N. (2013) · Medicina Clínica · doi:10.1016/j.medcli.2012.11.032 · Cited by 8
Alonso, C. V., Carmona, T. G., & Díaz, M. J. (2011) · Medicina Intensiva · doi:10.1016/s0210-5691(11)70010-9 · Cited by 7
Nutritional Management of Patients Treated with Continuous Renal Replacement Therapy
Chua, H., & Bellomo, R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391934-2.00037-0 · Cited by 7
Cardiovascular Safety of Antidiabetic Drugs in the Hospital Setting
Seggelke, S. A., Lindsay, M. C., Hazlett, I., Sanagorski, R., Eckel, R. H., & Wang, C. C. L. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0884-1 · Cited by 7
Beardsall, K., Thomson, L., Guy, C., Bond, S. J., Allison, A., Pantaleo, B., Petrou, S., Kim, S. W., Dunger, D. B., & Hovorka, R. (2021) · Efficacy and Mechanism Evaluation · doi:10.3310/eme08160 · Cited by 8
Infusão de insulina em terapia intensiva: ensaio controlado randomizado
Miranda, M. P. F., Crespo, J. C. L., & Secoli, S. R. (2013) · Revista da Escola de Enfermagem da USP · doi:10.1590/s0080-623420130000300013 · Cited by 7
The benefits of tight glycemic control in critical illness: Sweeter than assumed?
Gardner, A. J. (2014) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.146315 · Cited by 10
“GLUCONTROL), radically increase the risk of hypoglycemia as hormonal regulation changes.[14,30] This necessitates models which are easily able to adapt to the changing requirements of critically ill patients.”
InfluentialOptimal target range for blood glucose in hyperglycaemic patients in a neurocritical care unit
Guo, Y., Zhou, Y., Zhang, S.-Y., Wei, Q., Huang, Y., Xia, W., & Wang, S. (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114530580 · Cited by 7
A Novel Computerized Fading Memory Algorithm for Glycemic Control in Postoperative Surgical Patients
Horibe, M., Nair, B. G., Yurina, G., Neradilek, M. B., & Rozet, I. (2012) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318259ee31 · Cited by 9
“However, similar studies 8–11 that were subsequently conducted have produced conflicting re-sults.”
ResultGarazi, E., Bridge, S., Caffarelli, A. D., Ruoss, S. J., & van der Starre, P. (2015) · A & A Case Reports · doi:10.1213/xaa.0000000000000112 · Cited by 8
The optimal blood glucose level for critically ill adult patients
Lv, S., Ross, P., & Tori, K. E. (2017) · Nursing in Critical Care · doi:10.1111/nicc.12285 · Cited by 7
Year in review 2008: Critical Care - metabolism
Preiser, J. (2009) · Critical Care · doi:10.1186/cc8024 · Cited by 7
Self-citationZabolotskikh, I. B., Malyshev, Y. P., Вадимович, Д. П., Лебединский, К. М., Лейдерман, И. Н., Неймарк, М. И., Semenikhina, Т. М., & Yaroshetskiy, A. I. (2023) · Annals of critical care · doi:10.21320/1818-474x-2023-1-14-33 · Cited by 8
Perioperative and Critical Illness Dysglycemia—Controlling the Iceberg
Keegan, M. T., Goldberg, M. E., Torjman, M. C., & Coursin, D. B. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300608 · Cited by 8
Klee, P., Arni, D., Saudan, S., Schwitzgebel, V., Sharma, R., Karam, O., & Rimensberger, P. C. (2016) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000880 · Cited by 7
Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis
Preiser, J., & Marik, P. E. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181d8a38b · Cited by 7
Self-citationModel-Based Decision Support in Glycaemic Control
Fisk, L. (2014) · UC Research Repository (University of Canterbury) · doi:10.26021/3288 · Cited by 9
Jalleh, R. J., Wu, T., Umapathysivam, M. M., Young, R. L., Jones, K. L., Marathe, C. S., Rayner, C. K., Plummer, M. P., & Horowitz, M. (2026) · Physiological Reviews · doi:10.1152/physrev.00009.2025 · Cited by 6
Immune-modulating interventions in critically ill septic patients: pharmacological options
Toft, P., & Tønnesen, E. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.25 · Cited by 6
Updates on the Management of Hyperglycemia in Hospitalized Adult Patients
Razavi, L., & Omoregie, C. (2023) · Endocrines · doi:10.3390/endocrines4030037 · Cited by 7
“However, the risk of hypoglycemia was increased in the intensive tight glycemic group (8.7% vs. 2.7% p 0.0001) [39].”
BackgroundMethodInfluentialChai, T. Y., Tonks, K. T. T., & Campbell, L. V. (2015) · Australasian Medical Journal · doi:10.4066/amj.2015.2351 · Cited by 6
How to Prescribe Nutritional Support Using Computers
Berger, M. M. (2012) · World review of nutrition and dietetics · doi:10.1159/000341250 · Cited by 6
Non-ICU Hospital Care of Diabetes Mellitus in the Elderly Population
Gilden, J. L., & Gupta, A. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0596-3 · Cited by 7
Glucose Elevations and Outcome in Critically Injured Trauma Patients
DuBose, J. J., & Scalea, T. M. (2011) · Advances in Surgery · doi:10.1016/j.yasu.2011.03.016 · Cited by 6
“The studies failed to achieve the same degree of glucose control as Van den Berghe and colleagues and also failed to support the subsequent benefit of these intensive glucose control practices in this environment [21–24].”
ResultLi, L., Chen, Q., Chen, Q., Wu, R., Wang, S., & Yao, C. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s250133 · Cited by 6
Kaddoum, R. N., Khalili, A., Shebbo, F. M., Ghanem, N., Daher, L. A., Ali, A. B., Chehade, N. E. H., Maroun, P., & Aouad, M. T. (2022) · BMC Anesthesiology · doi:10.1186/s12871-022-01721-6 · Cited by 6
“However, normoglycemia is not easy to establish, and barriers to widespread adoption of tight glucose control were many including an increased risk of severe hypoglycemia, a difficulty in achieving normoglycemia, as well as an increase in the resources and the workload for medical staff [6, 7].”
BackgroundThe Golden Hours in Paediatric Septic Shock—Current Updates and Recommendations
Chong, S. L., Ong, G. Y., Anantharaman, V., & Chan, Y. H. (2014) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v43n5p267 · Cited by 6
Waeschle, R. M., Bräuer, A., Hilgers, R., Herrmann, P., Neumann, P., Quintel, M., & Moerer, O. (2013) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12239 · Cited by 7
“Two further RCTs (Glucontrol and VISEP) were prematurely stopped because of an increased risk of critical hypoglycaemia from the IIT in mixed medicosurgical (Glucontrol), and severe sepsis/septic shock patients (VISEP).(5,9) Critical hypoglycaemia was shown to be an independent risk factor for mortality, even after an…”
BackgroundResultCurrent state of glycemic control in critically ill subjects in a general intensive care unit
Zochios, V., Wilkinson, J., & Perry (2012) · International Journal of General Medicine · doi:10.2147/ijgm.s28570 · Cited by 6
Diabetes and Stress Hyperglycemia in the Intensive Care Unit: Outcomes After Cardiac Surgery
Gianchandani, R. Y., Esfandiari, N. H., Haft, J. W., Prager, R. L., & Pop‐Busui, R. (2012) · Hospital Practice · doi:10.3810/hp.2012.04.966 · Cited by 6
Ichaï, C. (2009) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2009.10.008 · Cited by 6
Abdelmalak, B., Duncan, A. E., Bonilla, A. M., Yang, D., Parra-Sánchez, I., Fergany, A. F., Irefin, S. A., & Sessler, D. I. (2016) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2015.10.005 · Cited by 6
“Some algorithms include patient-related factors such as weight,[8] and diabetic status,[13,15] while others do not.[4-6] There is no consensus about which baseline factors should be included, although insulin sensitivity has been related to various factors in non-operative settings.”
BackgroundPost-operative stress hyperglycemia is a predictor of mortality in liver transplantation
Giráldez, E., Varó, E., Guler, I., Cadarso-Suárez, C., Tomé, S., Barral, P., Garrote, A., & Gudé, F. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0334-5 · Cited by 8
Dysglycemia and Neurologic Outcome in Mechanically Ventilated Patients With Guillain-Barré Syndrome
Polito, A., Polito, A., Bouchereau, E., Moneger, G., Ritzenthaler, T., Annane, D., Heming, N., & Sharshar, T. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003635 · Cited by 6
Self-citationRodríguez-Calero, M. Á., Llodrá, E. B., Cuberos, M. C., Blanco‐Mavillard, I., & Axartell, M. A. P. (2019) · Enfermería Intensiva (English ed ) · doi:10.1016/j.enfie.2018.01.004 · Cited by 7
“03% incidence in this group, very much below the majority of published series.(18,20,32) The computer tool was useful in preventing the main complication in these patients and an independent cause of mortality.”
BackgroundResultCanbolat, Ö., Kapucu, S., & Kılıçkaya, O. (2019) · Critical Care Nurse · doi:10.4037/ccn2019431 · Cited by 7
Zhao, Y., Wu, Y., & Xiang, B. (2017) · Pediatric Research · doi:10.1038/pr.2017.310 · Cited by 7
Barletta, J. F., McAllen, K. J., Eriksson, E. A., Deines, G., Blau, S. A., Thayer, S. C., & Senagore, A. J. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0227 · Cited by 6
Significant Publications for Pharmacy Nutrition Support Practice in 2013
Dickerson, R. N., Kumpf, V. J., Rollins, C. J., Frankel, E. H., Kraft, M. D., Canada, T. W., & Crill, C. M. (2014) · Hospital Pharmacy · doi:10.1310/hpj4908-717 · Cited by 6
A liberal glycemic target in critically ill patients with poorly controlled diabetes?
Gunst, J., & den Berghe, G. V. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.10.28 · Cited by 6
“Subsequent multicenter RCTs no longer compared TGC to severe hyperglycemia, but to an intermediate glycemic target, in general <180 mg/dL (10 mmol/L) (9-12).”
BackgroundGuidelines for Nutrition in the Critically Ill: Are We Altogether or in‐the‐Altogether?
Griffiths, R. (2010) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607110363290 · Cited by 5
Uyttendaele, V., Dickson, J. L., Shaw, G., Desaive, T., & Chase, J. G. (2017) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2017.08.1159 · Cited by 5
“However, more recent trials have failed to reproduce these results, and have shown higher risks of hypoglycaemia (Griesdale et al., 2009, Wiener et al., 2008, Preiser et al., 2009, Finfer et al., 2009).”
ResultAdigbli, D. K., Li, Y., Hammond, N. E., Annane, D., Arabi, Y. M., Bilotta, F., Bohé, J., Brunkhorst, F. M., Cavalcanti, A. B., Cook, D., et al. (2023) · Critical Care Science · doi:10.5935/2965-2774.20230162-en · Cited by 5
Self-citationRangel, É. B. (2024) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2024-0074en · Cited by 5
Variability of insulin sensitivity during the first 4 days of critical illness
Pretty, C. G., Compte, A. L., Chase, J. G., Shaw, G. M., Preiser, J.-C., Penning, S., & Desaive, T. (2012) · Critical Care · doi:10.1186/cc10774 · Cited by 5
Self-citationGlycemic control in critically ill surgical patients: risks and benefits
May, A. K., Mukherjee, K., Albaugh, V. L., Richards, J. E., & Rumbaugh, K. A. (2015) · Open Access Surgery · doi:10.2147/oas.s50416 · Cited by 5
Reducing Mortality in the Perioperative Period
Landoni, G., Zangrillo, A., & Ruggeri, L. (2013) · Springer eBooks · doi:10.1007/978-3-319-02186-7 · Cited by 5
How should we interpret retrospective blood glucose measurements? Sampling and Interpolation
Stewart, K. W., Thomas, F., Pretty, C. G., Chase, J. G., & Shaw, G. M. (2017) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2017.08.266 · Cited by 5
“…protocols in the intensive care unit (ICU) use a range of different blood glucose (BG) measurement intervals (0.5 – 4 hours), depending on patient’s BG (Chase, Shaw, et al. , 2008; Finfer et al. , 2009; Preiser et al. , 2009; Amrein et al. , 2012; Van Herpe et al. , 2013; Stewart et al. , 2016).”
BackgroundInfluentialBochicchio, G. V., Nasraway, S. A., Moore, L. J., Furnary, A. P., Nohra, E. A., Bochicchio, K. M., Boyd, J. C., Bruns, D. I., Hirsch, I. B., Preiser, J., et al. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819886917 · Cited by 5
“The interventional trials used intermittent BG monitoring and their time in targeted BG range was explicitly disclosed in only one study.(24) However, based on their achieved mean and standard deviation of the mean, one can infer that the time in targeted BG range was likely <50% in all but one study.”
BackgroundSelf-citationType 1 Diabetes Overview and Perioperative Management
Nelson, G., & Sumpter, K. (2023) · Orthopedic Clinics of North America · doi:10.1016/j.ocl.2023.02.001 · Cited by 5
Clinical trial validation of the STAR-3D glycemic control framework
Uyttendaele, V., Knopp, J. L., Desaive, T., & Chase, J. G. (2023) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2023.10.1239 · Cited by 5
Control de la glucemia en el paciente crítico
García‐Acuña, J. M., & Assi, E. A. (2015) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(15)30026-1 · Cited by 13
Herpe, T. V., Gielen, M., Vanhonsebrouck, K., Wouters, P. J., den Berghe, G. V., Moor, B. D., & Mesotten, D. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500223 · Cited by 5
Hill, H., Baines, P. B., Barton, P., Newland, P., Terlouw, D. J., & Turner, M. A. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2302-5 · Cited by 5
“[22–24].”
Blood sugar control in the intensive care unit: time to relook
Rapsang, A. G., & Shyam, D. C. (2014) · Southern African Journal of Anaesthesia and Analgesia · doi:10.1080/22201181.2015.959363 · Cited by 5
Hypoglycemia in critically ill adults - association yes, causation not proven
Finfer, S. R. (2011) · Critical Care · doi:10.1186/cc10427 · Cited by 5
“Krinsley and colleagues report on a cohort of patients drawn from a hospital in the US, patients from three hospitals in Th e Netherlands, and patients recruited to the Glucontrol Study [6].”
BackgroundPhysiopathologie de la dénutrition en réanimation
Hssain, A. A., Souweine, B., & Cano, N. (2010) · Réanimation · doi:10.1016/j.reaurg.2010.06.009 · Cited by 5
Optimizing Inpatient Glycemic Control with Basal-Bolus Insulin Therapy
Pollom, R. D. (2010) · Hospital Practice · doi:10.3810/hp.2010.11.346 · Cited by 5
Modeling glucose and subcutaneous insulin dynamics in critical care
Pritchard‐Bell, A., Clermont, G., Knab, T. D., Maalouf, J., Vilkhovoy, M., & Parker, R. S. (2016) · Control Engineering Practice · doi:10.1016/j.conengprac.2016.07.005 · Cited by 6
In-Silico Analysis of Stochastic Modelling of Human Blood Glucose Regulatory System
Benyó, B. I. (2019) · IEEE International Conference on Intelligent Engineering Systems (INES) · doi:10.1109/ines46365.2019.9109467 · Cited by 5
“Num patients 20 20 20 Total hours 1915 2000 2222 Age (years) 65[55-69] 67[54-70] 66[52-72] Gender (M/F) 6/14 6/14 11/9 APACHE II [IQR] 24 [19-28] 33 [29-37] N/A ICU LoS [IQR] 20 [7-36] 14 [8-20] N/A”
Tian, Y., Li, T., Zhang, M., Wang, R., Ma, C., Guo, Y., & Wang, R. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.009 · Cited by 5
Conventional Glycaemic Control May Not Be Beneficial in Diabetic Patients Following Cardiac Surgery
Bayfield, N. G. R., Bibo, L., Budgeon, C. A., Larbalestier, R. I., & Briffa, T. G. (2022) · Heart Lung and Circulation · doi:10.1016/j.hlc.2022.08.013 · Cited by 5
[Styrene-induced occupational asthma and rhinitis].
Moscato, G., Marraccini, P., Dellabianca, A., Vinci, G., & Candura, S. M. (1988) · PubMed · Cited by 5
Polytraumaversorgung auf der Intensivstation
Mann, V., Mann, S. T. W., Szalay, G., Hirschburger, M., Röhrig, R., Dictus, C., Wurmb, T. E., Weigand, M. A., & Bernhard, M. H. (2010) · Der Anaesthesist · doi:10.1007/s00101-010-1771-1 · Cited by 11
Sodium, potassium and glucose management in organ transplantation
Keegan, M. T., & Wright, D. R. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283387f5e · Cited by 5
Tight glycemic control: what do we really know, and what should we expect?
Nasraway, S. A., & Rattan, R. (2010) · Critical Care · doi:10.1186/cc9236 · Cited by 4
Statlender, L., Robinson, E., Grossman, A., Duskin-Bitan, H., Shochat, T., Itzhaki, M. H., Fishman, G., Singer, P., Kagan, I., & Bendavid, I. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.11.024 · Cited by 4
Self-citationNya‐Ngatchou, J. J., Corl, D. E., Onstad, S., Yin, T. S., Tylee, T. S., Suhr, L. D., Thompson, R. E., & Wisse, B. E. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2575 · Cited by 4
Glycemic Control: How Tight in the Intensive Care Unit?
Weiss, A., & Mechanick, J. I. (2011) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2011.04.006 · Cited by 4
Evaluation of an adult insulin infusion protocol at an academic medical center.
Petrov, K. I., Burns, T. L., & Drincic, A. (2012) · Europe PMC (PubMed Central) · Cited by 4
Lam, S. W., Bauer, S. R., Yang, W. P., & Miano, T. A. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028016686356 · Cited by 5
Dynamic properties of glucose complexity during the course of critical illness: a pilot study
Godat, E., Preiser, J., Aude, J.-C., & Kalfon, P. (2019) · Journal of Clinical Monitoring and Computing · doi:10.1007/s10877-019-00299-8 · Cited by 5
Self-citationPark, S. W., Lee, S., Cha, W. C., Hur, K. Y., Kim, J. H., Lee, M.-K., Park, S., & Jin, S. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0227 · Cited by 4
Zeitoun, M. H., Abdel-Rahim, A., Hasanin, M. M., Hadidi, A. S. E., & Shahin, W. A. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.03.024 · Cited by 4
Rahimpour, F., Nejati, M., Moghaddas, A., Farsaei, S., & Feizi, A. (2023) · Journal of Research in Pharmacy Practice · doi:10.4103/jrpp.jrpp_45_23 · Cited by 4
“Two subsequent multicenter RCTs of TGC (Glucontrol [24] and VISEP [25] ) were prematurely stopped due to demonstrating no benefit and a higher risk of hypoglycemia.”
BackgroundButala, N. M., Johnson, B. K., Dziura, J. D., Reynolds, J. S., Bozzo, J., Balcezak, T. J., Inzucchi, S. E., & Horwitz, L. I. (2015) · Journal of Hospital Medicine · doi:10.1002/jhm.2321 · Cited by 4
Metadata
- Authors
- Preiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., Wernerman, J., Joannidis, M., Stecher, A., & Chioléro, R.
- Affiliations
- Centre Hospitalier Universitaire de Liège (BE)
- Erasmus Hospital (BE)
- Hôpital Raymond-Poincaré (FR)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- University of Milan (IT)
- Université Joseph Fourier (FR)
- Institut Gustave Roussy (FR)
- Rabin Medical Center (IL)
- Karolinska Institutet (SE)
- Universität Innsbruck (AT)
- Ljubljana University Medical Centre (SI)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Preiser, Jean-Charles
- ORCID
- Venue
- Intensive Care Medicine
- Published
- 2009-07-28
- Volume
- 35
- Issue
- 10
- Pages
- 1738-1748
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2139706988
- Cited by
- 911
- References
- 37
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 24 · 2023: 33 · 2022: 23 · 2021: 32 · 2020: 31 · 2019: 48 · 2018: 48 · 2017: 46 · 2016: 57 · 2015: 69 · 2014: 80 · 2013: 76 · 2012: 95
- FWCI
- 75.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion)
- Acceda (Universidad de Las Palmas de Gran Canaria) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Universidad de Las Palmas de Gran Canaria
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- intensive insulin therapy, tight glycemic control, glycemic targets, critically ill adults, intensive care unit, ICU mortality, hypoglycemia, insulin therapy, early trial termination, protocol violations, time in target glucose range, ICU length of stay, cost-effectiveness, quality of life
- MeSH terms
- Aged, Blood Glucose, Female, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Intensive Care Units, Male, Middle Aged, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.